Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R21DK085483-01 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
FL3X is an integrated diabetes self-management system that incorporates modern cell phone technology with behavioral modification approaches to improve diabetes self-management in high-risk youth. Utilizing such approaches will increase adherence to diabetes management behaviors and improve glucose control by providing increased autonomy over diabetes care.
FL3X utilizes diabetes care providers (diabetes educators) as health coaches to employ behavioral modification techniques including motivational interviewing and problem solving skills training. Coaches help adolescents and their families learn these techniques to improve diabetes self management behaviors and diabetes care.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | No Intervention | Standard diabetes care | |
| Health coaching with technology support | Experimental | Behavioral strategies including problem solving skills building, family communication counseling, technology support, motivational interviewing support. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| health coaching with technology support | Behavioral | Intensive behavior change support. Engaging participants to take an active role in their diabetes care using motivational interviewing, technology, family communication, problem solving skills. |
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in HbA1c at 4 months | 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in Quality of Life measures at 4 months | Quality of Life will be assessed via self report questionnaire data. | 4 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Elizabeth Mayer-Davis, PhD | UNC-CH | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Colorado Barbara Davis Center for Childhood Diabetes | Aurora | Colorado | 80045 | United States | ||
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| WakeMed Hospital |
| Raleigh |
| North Carolina |
| 27610 |
| United States |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45206 | United States |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |